News
Mondelez Global LLC is recalling multiple carton sizes of Ritz peanut butter cracker sandwiches due to fears the product may ...
The 2024 National Youth Tobacco Survey found that 1.63 million kids — 5.9% of all U.S. middle and high school students — were current e-cigarette users. Over a quarter (26.3%) of those kids were using ...
The American Principles Project (APP) is calling on the Trump administration to take additional steps to protect children ...
Current guidelines suggest limiting diagnostic testing for chronic spontaneous urticaria when no clear cause is suspected, though biomarkers and biopsies are emerging as tools to predict treatment ...
A recall of Coca-Cola-owned Topo Chico mineral water for possible contamination received a Class II risk assignment from the ...
The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...
Whether you're just starting your skin-care journey or are a seasoned enthusiast, these are the best facial toning tools, ...
The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.
A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...
Star-favored, board-certified aesthetics physician Dr. Glenicia Nosworthy explains how to choose the right high-tech tool for ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results